Synonyms: | |
Status: | Approved (1999) Withdrawn (2010) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | A10BG02 |
UNII: | 05V02F2KDG |
InChI Key | YASAKCUCGLMORW-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C18H19N3O3S |
Molecular Weight | 357.44 |
AlogP | 2.49 |
Hydrogen Bond Acceptor | 6.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 7.0 |
Polar Surface Area | 71.53 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 25.0 |
Primary Target | |
---|---|
Peroxisome proliferator-activated receptor-γ |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Alzheimer Disease | 3 | D000544 | ClinicalTrials |
Coronary Disease | 3 | D003327 | ClinicalTrials |
Diabetes Mellitus, Type 2 | 3 | D003924 | ClinicalTrials |
Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
Diabetic Neuropathies | 3 | D003929 | ClinicalTrials |
Lipid Metabolism Disorders | 3 | D052439 | ClinicalTrials |
Metabolic Syndrome | 3 | D024821 | ClinicalTrials |
Multiple Organ Failure | 3 | D009102 | ClinicalTrials |
Hypertension | 3 | D006973 | ClinicalTrials |
Metabolic Diseases | 3 | D008659 | ClinicalTrials |
Glucose Intolerance | 3 | D018149 | ClinicalTrials |
Atherosclerosis | 3 | D050197 | ClinicalTrials |
Glucose Intolerance | 3 | D018149 | ClinicalTrials |
Hypercholesterolemia | 3 | D006937 | ClinicalTrials |
Non-alcoholic Fatty Liver Disease | 2 | D065626 | ClinicalTrials |
Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
Prediabetic State | 2 | D011236 | ClinicalTrials |
Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
Insulin Resistance | 2 | D007333 | ClinicalTrials |
HIV Infections | 2 | D015658 | ClinicalTrials |
Sezary Syndrome | 2 | D012751 | ClinicalTrials |
Asthma | 2 | D001249 | ClinicalTrials |
Endometriosis | 2 | D004715 | ClinicalTrials |
Cognitive Dysfunction | 2 | D060825 | ClinicalTrials |
Mycosis Fungoides | 2 | D009182 | ClinicalTrials |
Erectile Dysfunction | 1 | D007172 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Malaria | 1 | D008288 | ClinicalTrials |
Anemia | 1 | D000740 | ClinicalTrials |
Nausea | 1 | D009325 | ClinicalTrials |
Glomerulosclerosis, Focal Segmental | 1 | D005923 | ClinicalTrials |
Breast Neoplasms | 1 | D001943 | ClinicalTrials |
Malaria, Falciparum | 1 | D016778 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 122320-73-4 |
ChEBI | 50122 |
ChEMBL | CHEMBL121 |
DrugBank | DB00412 |
DrugCentral | 2405 |
EPA CompTox | DTXSID7037131 |
FDA SRS | 05V02F2KDG |
Human Metabolome Database | HMDB0005031 |
Guide to Pharmacology | 1056 |
PharmGKB | PA451283 |
PubChem | 77999 |
SureChEMBL | SCHEMBL5169 |